Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers.

Autor: Gentileschi S; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy., Cannistrà C; Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, 50134 Florence, Italy., Gaggiano C; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy., Damiani A; Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, 50134 Florence, Italy., Carli L; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy., Benucci M; Rheumatology Unit, S. Giovanni Di Dio Firenze Hospital, 50134 Florence, Italy., Cantini F; Rheumatology Unit, S. Stefano Hospital, 59100 Prato, Italy., Niccoli L; Rheumatology Unit, S. Stefano Hospital, 59100 Prato, Italy., Vitale A; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy., Baldi C; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy., Delle Sedie A; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy., Cantarini L; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy., Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy., Frediani B; Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy., Guiducci S; Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, 50134 Florence, Italy.

Publikováno v: Journal of personalized medicine [J Pers Med] 2024 Nov 14; Vol. 14 (11). Date of Electronic Publication: 2024 Nov 14.

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data

Autor: Benucci M, Damiani A, Li Gobbi F, Grossi V, Infantino M, Manfredi M, Niccoli L, Cantini F

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 16, Pp 287-297 (2020)

Maurizio Benucci,1 Arianna Damiani,2 Francesca Li Gobbi,1 Valentina Grossi,3 Maria Infantino,3 Mariangela Manfredi,3 Laura Niccoli,4 Fabrizio Cantini4 1Rheumatology Unit, Hospital S. Giovanni di Dio, Azienda USL-Toscana Centro, Florence, Italy; 2Rheu

Externí odkaz: https://doaj.org/article/4f08e2754095488097299a6d5dd3953f

Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life

Autor: Benucci M, Damiani A, Manfredi M, Infantino M, Grossi V, Li Gobbi F

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 11, Pp 405-409 (2019)

Maurizio Benucci,1 Arianna Damiani,1 Mariangela Manfredi,2 Maria Infantino,2 Valentina Grossi,2 Francesca Li Gobbi11Rheumatology Unit, S.Giovanni di Dio Hospital, Florence, Italy; 2Immunology and Allergology Laboratory Unit, S.Giovanni di Dio Hospita

Externí odkaz: https://doaj.org/article/a9cd5325e0de4880b761292c15adc1a8

A better definition of the anti-DFS70 antibody screening by IIF methods

Autor: Infantino, M., Shovman, O., Pérez, D., Grossi, V., Manfredi, M., Benucci, M., Damiani, A., Gilburd, B., Azoulay, D., Serrano, A., Shoenfeld, Y.

Publikováno v: In Journal of Immunological Methods October 2018 461:110-116

Focus on biosimilar etanercept – bioequivalence and interchangeability

Autor: Cantini F, Benucci M

Publikováno v: Biologics: Targets & Therapy, Vol Volume 12, Pp 87-95 (2018)

Fabrizio Cantini,1 Maurizio Benucci2 1Department of Rheumatology, Hospital of Prato, Prato, Italy; 2Rheumatology Unit, Hospital S. Giovanni di Dio, Florence, Italy Background: The recent approval of reference etanercept (re-ETN) biosimilars SB4, GP20

Externí odkaz: https://doaj.org/article/c540f359f2044d96b0363c07a318a60c